MMP-9 (Gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients

Cancer Investigation

Volumn 28, Issue 1, 2010, Pages 38-43

  Bendardaf, Riyad ^a   Buhmeida, Abdelbaset ^a   Hilska, Marja ^a   Laato, Matti ^a   Syräjnen, Stina ^a   Syrjänen, Kari ^a   Collan, Yrjö ^a   Pyrhönen, Seppo ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Clinico pathological data; Colorectal carcinoma; Immunohistochemistry; MMP 9; Patients survival

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION;

AGED; CARCINOMA; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TIME FACTORS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 72449139066     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900802672761     Document Type: Article

References (24)

1. Chambers, A.F.; Matrisian, L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997, 89(17), 1260-1270.
2. Coussens, L.M.; Werb, Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996, 3, 895-904.
3. Kelly, T.; Yan, Y.; Osborne, R.L.; Athota, A.B.; Rozypal, T.L.; Colclasure, J.C.; Chu, W.S. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998, 16, 501-512.
4. Nikkola, J.; Vihinen, P.; Vlaykova, T.; Hahka-Kemppinen, M.; Kahari, V.M.; Pyrhonen, S. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 2002, 97, 432-438.
5. Kahari, V.M.; Saarialho-Kere, U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999, 31, 34-45.
6. Kleiner, D.E.; Stetler-Stevenson, W.G. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999, 43, 42-51.
7. Liotta, L.A.; Tryggvason, K.; Garbisa, S.; Hart, I.; Foltz, C.M.; Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980, 284, 67-68. (Pubitemid 10098769)
8. Yamaguchi, A.; Kurosaka, Y.; Ishida, T.; Nishimura, G.; Kanno, M.; Kosaka, T.; Yonemura, Y.;Miyazaki, I. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers. Dis Colon Rectum 1991, 34, 921-924.
9. Inoue, T.; Yashiro, M.; Nishimura, S.; Maeda, K.; Sawada, T.; Ogawa, Y.; Sowa, M.; Chung, K.H. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int J Mol Med 1999, 4, 73-77.
10. Murray, G.I.; Duncan, M.E.; O'Neil, P.; Melvin,W.T.; Fothergill, J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996, 2, 461-462.
11. Ito, T.; Ito, M.; Shiozawa, J.; Naito, S.; Kanematsu, T.; Sekine, I. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod Pathol 1999, 12, 669-674.
12. Grigioni, W.F.; D'Errico, A.; Fortunato, C.; Fiorentino, M.; Mancini, A.M.; Stetler-Stevenson, W.G.; Sobel, M.E.; Liotta, L.A.; Onisto, M.; Garbisa, S. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 1994, 7, 220-225.
13. Miyajima, Y.; Nakano, R.; Morimatsu, M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 1995, 104, 678-684.
14. Westerlund, A.; Apaja-Sarkkinen, M.; Hoyhtya, M.; Puistola, U.; Turpeenniemi-Hujanen, T. Gelatinase A-immunoreactive protein in ovarian lesions- prognostic value in epithelial ovarian cancer. Gynecol Oncol 1999, 75, 91-98.
15. Passlick, B.; Sienel, W.; Seen-Hibler, R.; Wockel, W.; Thetter, O.; Mutschler, W.; Pantel, K. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000, 6, 3944-3948.
16. Davidson, B.; Goldberg, I.; Kopolovic, J.; Lerner-Geva, L.; Gotlieb, W.H.; Ben-Baruch, G.; Reich, R. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 1999, 73, 372-382.
17. Talvensaari-Mattila, A.; Paakko, P.; Hoyhtya, M.; Blanco-Sequeiros, G.; Turpeenniemi-Hujanen, T. Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma. Cancer 1998, 83, 1153-1162.
18. Murray, D.; Morrin, M.; McDonnell, S. Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44- dependent mechanism. Anticancer Res 2004, 24, 489-494.
19. Unsal, D.Akyurek, N.; Uner, A.; Erpolat, O.P.; Han, U.; Akmansu, M.; Mentes, B.B.; Dursun, A. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy. Am J Clin Oncol 2008, 31, 55-63.
20. Zeng, Z.S.; Huang, Y.; Cohen, A.M.; Guillem, J.G. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996, 14, 3133-3140.
21. Ring, P.; Johansson, K.; Hoyhtya, M.; Rubin, K.; Lindmark, G. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer-a predictor of tumour stage. Br J Cancer 1997, 76, 805-811.
22. Bufill, J.A. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990, 113, 779-788.
23. Bleeker, W.A.; Hayes, V.M.; Karrenbeld, A.; Hofstra, R.M.; Hermans, J.; Buys, C.C.; Plukker, J.T. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Am J Gastroenterol 2000, 95, 2953-2957.
24. Elsaleh, H.; Joseph, D.; Grieu, F.; Zeps, N.; Spry, N.; Iacopetta, B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000, 355, 1745-1750.